CanineCeuticals Mushroom Elixir: Veterinary Product Profile

CanineCeuticals Mushroom Elixir is a named branded product for Dogs; the manufacturer page also provides cat guidance, so the physical label must confirm cross-species use; manufacturer positioning is kept separate from independent clinical and regulatory evidence.

100 mL oral liquid multi-mushroom extract. Intended species: Dogs; the manufacturer page also provides cat guidance, so the physical label must confirm cross-species use.

The official page lists Ganoderma lucidum or Reishi, Lentinula edodes or Shiitake, Grifola frondosa or Maitake, Trametes versicolor or Turkey Tail, and Cordyceps sinensis. It states that each 1 mL contains the equivalent of 500 mg dried mushroom and that whole fruiting bodies are used. The product is described as free from alcohol, glycerine, artificial flavours, and sweeteners.

CanineCeuticals markets Mushroom Elixir for immune, stress, energy, gut, liver, cardiovascular, and general wellbeing support. It is positioned for dogs and, in the manufacturer guidance, cats. These broad wellness and biological statements identify intended support but do not establish treatment of a tumour or a universal benefit in oncology patients.

May be discussed only as supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive objective, baseline, review date, adverse-event plan, and stopping rule with the veterinarian.

Bring the current label, lot, full ingredient panel, country version, complete diet, medicines, and supplements to the treating veterinarian.

The official page verifies the named five-mushroom mixture, liquid form, declared dried-mushroom equivalent, and cautions. No controlled canine or feline oncology trial of this finished combination was identified. Evidence for one purified Turkey Tail PSP product, one mushroom, or a human mixture cannot be transferred to this multi-mushroom liquid.

The manufacturer cautions about immunosuppressive medicines, anticoagulant or antiplatelet medicines, pregnancy or lactation, and use around surgery. This entry does not recreate timing instructions. Review autoimmune disease, mushroom allergy, gastrointestinal tolerance, diabetes, blood pressure, liver or kidney disease, anaesthesia, chemotherapy, and all other supplements. Cat use requires explicit label and veterinarian confirmation.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

The manufacturer markets the product in Australia as a nutritional feed supplement and states that its product claims have not been evaluated by the APVMA. No APVMA registration as a veterinary anticancer medicine was verified. Cross-border or cat availability must be confirmed from the local package.

Australia

Record species, bottle, lot, expiry, label, start date, medicines, surgery or treatment dates, and supportive objective. Track appetite, vomiting, stool, itching, swelling, energy, weight, bleeding or bruising, and prescribed-treatment tolerance. Ask whether blood counts, chemistry, coagulation, or other treatment-specific monitoring should change; maintain objective tumour follow-up.